Meanwhile, we found a similar decrease of drug-resistant genes (ABCB1, ABCC1, and ABCG2) in lung cancer spheroids after apatinib treatment, which was further confirmed in CDDP-resistant A549 cells. The gene discussed is ABCG2; the disease is lung carcinoma.